In the current study, we assessed the effects of BCar on clonogenic cell survival in the context of apoptosis, senescence, mitotic catastrophe, and autophagy using a panel of BC cells, with/without p53 function, and in normal breast cells. This evidence concerns the gene TP53 and breast cancer.